BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25104200)

  • 1. Proteomics analysis of human brain glial cell proteome by 2D gel.
    Pooladi M; Abad SK; Hashemi M
    Indian J Cancer; 2014; 51(2):159-62. PubMed ID: 25104200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The investigation of changes in proteins expression (Apolipoprotein A1 and albumin) in malignant astrocytoma brain tumor.
    Hashemi M; Pooladi M; Razi Abad SK
    J Cancer Res Ther; 2014; 10(1):107-11. PubMed ID: 24762496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome.
    Pooladi M; Rezaei-Tavirani M; Hashemi M; Hesami-Tackallou S; Khaghani-Razi-Abad S; Moradi A; Zali AR; Mousavi M; Firozi-Dalvand L; Rakhshan A; Zamanian Azodi M
    Iran J Cancer Prev; 2014; 7(2):87-95. PubMed ID: 25250155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics studies of childhood pilocytic astrocytoma.
    Anagnostopoulos AK; Dimas KS; Papathanassiou C; Braoudaki M; Anastasiadou E; Vougas K; Karamolegou K; Kontos H; Prodromou N; Tzortzatou-Stathopoulou F; Tsangaris GT
    J Proteome Res; 2011 May; 10(5):2555-65. PubMed ID: 21466243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis of human oligodendroglioma proteome.
    Khaghani-Razi-Abad S; Hashemi M; Pooladi M; Entezari M; Kazemi E
    Gene; 2015 Sep; 569(1):77-82. PubMed ID: 26002447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic studies on low- and high-grade human brain astrocytomas.
    Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A
    J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.
    Ohnishi M; Matsumoto T; Nagashio R; Kageyama T; Utsuki S; Oka H; Okayasu I; Sato Y
    Pathol Int; 2009 Nov; 59(11):797-803. PubMed ID: 19883430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential proteomics in glioblastoma].
    Zhao ZK; Jiang ZM; Liu XZ; Qi LS; Qin XJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):414-7. PubMed ID: 19781350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.
    Khwaja FW; Duke-Cohan JS; Brat DJ; Van Meir EG
    Clin Cancer Res; 2006 Nov; 12(21):6331-6. PubMed ID: 17085642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in the search for potential biomarkers by proteomics: application of principal component and discriminant analyses for two-dimensional maps evaluation.
    Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Páez de la Cadena M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):251-60. PubMed ID: 17071145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.
    Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC
    Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All about DIGE: quantification technology for differential-display 2D-gel proteomics.
    Lilley KS; Friedman DB
    Expert Rev Proteomics; 2004 Dec; 1(4):401-9. PubMed ID: 15966837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D-DIGE: comparative proteomics of cellular signalling pathways.
    Larbi NB; Jefferies C
    Methods Mol Biol; 2009; 517():105-32. PubMed ID: 19378013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of proteomics in the research of discrepancy proteins in gastric cancer].
    Ma B; Zhao JS; Ding DY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):534-7. PubMed ID: 17143804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity profile of cadmium revealed by proteomics in brain tissue of Paralichthys olivaceus: potential role of transferrin in cadmium toxicity.
    Zhu JY; Huang HQ; Bao XD; Lin QM; Cai Z
    Aquat Toxicol; 2006 Jun; 78(2):127-35. PubMed ID: 16647146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.